The Clinical Decision Support Coalition on April 27 released a draft of voluntary industry guidelines for software developers to use when designing clinical decision support solutions.
The guidelines focus on standards related to human intervention, transparency and ensuring adequate time to reflect on recommendations from a software solution.
"The purpose of these guidelines is to ensure that software, as much as possible, leaves the user firmly in control of the clinical decision-making," the CDS Coalition wrote.
The CDS Coalition — which includes representation from clinical societies, healthcare payers, healthcare providers, patient advocacy organizations and software developers — requests users and developers of CDS software to submit comment on the draft guidelines through July 1.
The coalition will send its final guidelines, which include input on how to regulate CDS software, to the U.S. Food and Drug Administration.
Click here to view the draft guidelines.